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The presence of Shiga toxin-producing Escherichia coli (STEC) in water buffaloes is reported for the first
time in South America. The prevalence of STEC ranged from 0 to 64% depending on the farm. STEC isolates
exhibiting the genetic profiles stx1stx2ehxA iha saa and stx2ehxA iha saa predominated. Of the 20 distinct
serotypes identified, more than 50% corresponded to serotypes associated with human diseases.
Shiga toxin-producing Escherichia coli (STEC) represents an
important emerging group of food-borne pathogens. Domestic
animals, particularly bovine and ovine, have been incriminated as
natural reservoirs of STEC all over the world (2, 7). Although
O157:H7 is known to be the most important STEC serotype in
many industrialized countries, hundreds of distinct STEC sero-
types have been isolated from human diseases in many geo-
graphic areas, including Brazil (3, 14, 16, 18, 29).
The presence of STEC in bovines and ovines in Brazil has
been described previously (5, 17, 19, 31); however, the preva-
lence of STEC in Brazilian water buffaloes remains unknown,
and all over the world very few data on the prevalence of STEC
in water buffaloes are available (7, 10, 21). The aim of this
study was to estimate the prevalence and the characteristics of
STEC in healthy dairy water buffaloes in Brazil, where they are
intensively reared and represent the most important herd in
the Americas (11).
A total of 100 healthy dairy water buffaloes from nine farms
located in the central area of Minas Gerais State, Brazil, were
studied. These animals were randomly selected and repre-
sented at least 10% of the herd on each farm. Fecal samples
that were collected with sterile swabs and dipped into 8 ml
Cary Blair transport medium were directly inoculated into 5 ml
of buffered peptone water and incubated overnight at 37°C.
Cultures were streaked onto MacConkey sorbitol agar and
incubated as described above. A total of 655 presumptively
(24) identified E. coli colonies (sorbitol positive and negative)
were investigated for the presence of the stx1,stx2, eae, and ehxA
genes using colony hybridization assays and specific DNA
probes (13).
STEC isolates were analyzed for the presence of genes cod-
ing for Saa, EfaI, ToxB, and Iha using colony hybridization
assays and specific DNA probes (22, 23, 26, 27, 28). Cytotox-
icity assays were performed as described by Gentry and Dal-
rymple (12), and the hemolytic activity was determined as
described by Beutin et al. (1). stx1 and stx2 subtypes were
determined for 56 strains representing one serotype from each
animal. The genetic variant stx1c was determined as described
by Zhang et al., (32), and differentiation of the stx2 variants was
carried out as described previously (30).
The antimicrobial susceptibility pattern (6) was determined for
56 strains representing one serotype from each animal. The fol-
lowing antimicrobial agents were tested: ampicillin, amikacin, ce-
foxitin, chloramphenicol, streptomycin, gentamicin, kanamycin,
nalidixic acid, tetracycline, tobramycin, trimethoprim-sulfa-
methoxazole, cefotaxime, ceftazidime, cefepime, piperacillin-
tazobactam, amoxicillin-clavulanic acid, aztreonam, imipenem,
and ceftriaxone.
O/H serotypes were identified by using standard methods (9)
and O (O1 to O181) and H (H1 to H56) antisera.
In accordance with worldwide data (15), the prevalence of
STEC in the present study ranged from 0 to 64.3% depending
on the farm (Table 1). STEC strains were not detected in
animals from two farms. However, more than 60% of the
animals from two farms carried STEC strains. These remark-
able differences in the prevalence of STEC depending on the
farm probably could be associated with the on-farm manage-
ment practices, such as manure handling, housing conditions,
diet, etc.
More than 70% of the STEC strains were typeable, and the
strains belonged to 20 distinct serotypes. More than 50% of the
serotypes and untypeable strains associated with H2, H7, H8,
H14, H16, H18, and H21 antigens identified in this study had
previously been described as serotypes and strains associated
with human illness (www.microbionet.com.au/vtectable.htm).
Seven serotypes, O23:H7, O74:H25, O77:H18, O82:H-, O93:
H16, O141:H49, and O176:H2, accounted for 47.7% of the
isolates. Serotype O74:H25 was the most frequent and was
recovered from animals reared on four of seven farms, sug-
gesting that there was widespread dissemination of certain
serotypes among distinct farms. Other serotypes, such as O77:
H18, O23:H7, and O141:H49, were recovered mostly from
water buffaloes reared on one farm. Although in the area
studied water buffaloes and other dairy and beef cattle are
usually reared together, serotypes O23:H7, O49:H21, O59:H8,
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TABLE 1. Distribution of serotypes and genetic profiles of STEC strains isolated from healthy dairy water buffaloes on different
farms of Minas Gerais, Brazil
Farma No. of animalsstudied
No. of STEC-positive
animals (%) Animal Serotype
b No. of isolates Genetic profile
A 16 2 (12.5) 29 O137:H41 1 stx1 ehxA iha saa
O74:H25 1 stx1 stx2vha ehxA iha saa
32 ONT:H7 1 stx2 ehxA iha saa
B 6 2 (33.3) 52 O159:H21 1 stx1 stx2vhb ehxA iha saa
54 O41:HNTc 1 stx1c ehxA iha saa
C 14 6 (42.8) 3 O77:H18 8 stx1 stx2vhb ehxA iha saa
ONT:H16c 1 stx2d ehxA iha
6 ONT:H21 2 stx1 stx2 ehxA iha saa
61 ONT:H21 1 stx1 stx2 ehxA iha saa
65 O88:H25c 3 stx1
67 O116:H21 1 stx2 ehxA iha saa
70 O77:H18 3 stx1 stx2/2vhb ehxA iha saa
D 14 9 (64.3) 14 O141:H49 6 stx2vha ehxA iha saa
15 O178:H19 1 stx2vhb ehxA iha saa
71 O23:H7 6 stx2 ehxA iha saa
73 O82:H8 2 stx2 ehxA iha saa
ONT:H7 1 stx2 ehxA iha saa
74 ONT:H18 2 stx1 stx2 ehxA iha saa
75 ONT:HNTc 1 stx1
O93:H19 2 stx1 ehxA iha saa
76 O116:H21 1 stx2 ehxA iha saa
O74:H25 1 stx1 stx2vha ehxA iha saa
ONT:H18 4 stx1 stx2 ehxA iha saa
79 O74:H25 4 stx1 stx2vha ehxA iha saa
80 ONT:H7 1 stx2 ehxA iha saa
E 10 4 (40.0) 81 O178:H19 2 stx2vhb ehxA iha saa
O77:H18 1 stx2vhb ehxA iha saa
83 O59:H8 1 stx2vha ehxA iha saa
85 O74:H25 2 stx1 stx2vha ehxA iha saa
89 O82:H- 4 stx2 ehxA iha saa
F 10 3 (30.0) 100 ONT:H42 1 stx1 stx2vhb ehxA iha saa
103 O113:H21 1 stx1 stx2vha iha
105 ONT:H7 1 stx1 ehxA iha saa
G 18 11 (61.1) 110 O93:H19 1 stx2 ehxA
O156:H21 2 stx1 stx2vha iha
ONT:H21 5 stx2unt ehxA iha saa
111 O156:H21 1 stx1 stx2vha iha
112 O74:H25c 3 stx1 stx2vha ehxA iha saa
114 O74:H25c 4 stx1 stx2vha ehxA iha saa
O22:H16 1 stx1 stx2 ehxA iha saa
ONT:H2 1 stx2vhb ehxA iha saa
115 O82:H8 1 stx2 ehxA iha saa
117 O49:HNTc 1 stx1c
O49:H21c 1 stx1c
118 O77:H41 1 stx1 ehxA iha saa
119 O176:H2 1 stx2vhb ehxA iha saa
O49:H21c 1 stx1c
ONT:H38c 2 stx1c
ONT:H14c 1 stx1c
121 O93:H16 (H-) 6 stx1 iha saa
ONT:HNT 1 stx1c
123 O79:H14 1 stx1 stx2vhb ehxA iha saa
ONT:H8 1 stx1c
126 O176:H2 3 stx2vhb ehxA iha saa
ONT:H2 1 stx2vhb ehxA iha saa
Total 100 37 (37) 109
a STEC was not detected on two farms (farms H and I).
b Bold type indicates serotypes associated with human diseases.
c Negative for the cytotoxicity assay with Vero cells.
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O74:H25, O77:H41, O93:H16, O93:H19, O137:H41, and
O176:H2, which accounted for 45% of the serotypes found in
water buffaloes, were not found among STEC strains from
dairy and beef cattle (data not shown).
Of the 109 STEC isolates, 42 (38.5%) carried stx2, 43
(39.5%) carried stx1 and stx2 sequences, and only 24 (22%)
harbored the stx1 sequence. The majority of STEC strains
belonging to serotypes not previously reported to be serotypes
associated with human illness and carrying the stx1 sequence
alone carried the stx1c subtype. These strains were devoid of
additional virulence factors and were negative for the cytotox-
icity assay with Vero cells. In contrast, STEC serotypes asso-
ciated with human diseases harbored stx2 or stx1 and stx2 se-
quences and belonged to the stx2, stx2vha, or stx2vhb subtype; one
strain belonged to the stx2d subtype, and one strain was un-
typeable with the method currently used. STEC isolates exhib-
iting the genetic profiles stx1 stx2 ehxA iha saa and stx2 ehxA iha
saa accounted for more than 70% of the isolates.
All STEC isolates were devoid of the eae gene. This result
can be related to the serotypes found in these animals. Ac-
cording to Sandhu et al. (25), the presence of the eae gene is
associated with certain O groups, such as O26, O103, O111,
O145, and O157, none of which was identified in the STEC in
the present study. The saa and iha gene sequences were de-
tected alone or in association in 83.5% of the STEC strains.
This wide distribution of Saa among eae-negative strains is in
agreement with the findings of Paton et al. (23). With the lack
of the eae gene, distinct adhesins other than intimin can have
an important role in adherence to the intestinal epithelium and
colonization of the gut. The ehxA gene sequence was detected
in 86 of the 109 STEC strains (78.9%), and all of the strains
expressed hemolytic activity after 18 to 24 h of incubation.
The majority of STEC strains were susceptible to all anti-
microbials tested. Resistance to one drug (nalidixic acid, strep-
tomycin, or ampicillin) and resistance to two antimicrobials
(ampicillin plus streptomycin and nalidixic acid plus ampicillin)
were found in 10 (17.8%) and 2 (3.6%) of the strains, respec-
tively.
The prevalence of STEC strains having the genetic profile
stx1 stx2 ehxA iha saa or stx2 ehxA iha saa deserves great atten-
tion as STEC strains carrying the stx2 gene are commonly
associated with more severe disease (4, 8). Moreover, these
strains carry other virulence genes, such as ehxA, iha, and saa,
which can enhance their virulence.
This is the first report of the presence of STEC in water
buffaloes in South America. Unpasteurized water buffalo milk
may represent a potential risk to public health since it is used
for homemade mozzarella production due to its high fat and
casein content (20).
Because water buffalo farming is increasing as an important
economic activity, control measures for hygienic practice, par-
ticularly in milking, surveillance, and legislation have to be
improved in order to prevent fecal contamination of milk and
dairy products.
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